These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38263984)

  • 21. Future of immune checkpoint inhibitors: focus on tumor immune microenvironment.
    Jia Y; Liu L; Shan B
    Ann Transl Med; 2020 Sep; 8(17):1095. PubMed ID: 33145314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative immune checkpoint inhibition for colorectal cancer: recent advances and future directions.
    Chen JT; Zhou YW; Han TR; Wei JL; Qiu M
    Front Immunol; 2023; 14():1269341. PubMed ID: 38022667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Immune Checkpoint Inhibitors in Colorectal Adenocarcinoma.
    Almquist DR; Ahn DH; Bekaii-Saab TS
    BioDrugs; 2020 Jun; 34(3):349-362. PubMed ID: 32246441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden.
    Quintanilha JCF; Graf RP; Fisher VA; Oxnard GR; Ellis H; Panarelli N; Lin DI; Li G; Huang RSP; Ross JS; Myer PA; Klempner SJ
    JAMA Netw Open; 2023 Jan; 6(1):e2252244. PubMed ID: 36689222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune checkpoint inhibitor resistance in hepatocellular carcinoma.
    Wang Z; Wang Y; Gao P; Ding J
    Cancer Lett; 2023 Feb; 555():216038. PubMed ID: 36529238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.
    Melosky B; Cheema PK; Brade A; McLeod D; Liu G; Price PW; Jao K; Schellenberg DD; Juergens R; Leighl N; Chu Q
    Oncologist; 2020 Nov; 25(11):981-992. PubMed ID: 32860288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer.
    Singh S; Numan A; Maddiboyina B; Arora S; Riadi Y; Md S; Alhakamy NA; Kesharwani P
    Drug Discov Today; 2021 Jul; 26(7):1721-1727. PubMed ID: 33745879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022.
    André T; Cohen R; Salem ME
    Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-9. PubMed ID: 35471834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
    Schlam I; Gatti-Mays ME
    Oncologist; 2022 Jul; 27(7):538-547. PubMed ID: 35598254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma.
    San-Román-Gil M; Torres-Jiménez J; Pozas J; Esteban-Villarrubia J; Albarrán-Fernández V; Álvarez-Ballesteros P; Chamorro-Pérez J; Rosero-Rodríguez D; Orejana-Martín I; Martínez-Delfrade Í; Reguera-Puertas P; Fuentes-Mateos R; Ferreiro-Monteagudo R
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy.
    Rizvi N; Ademuyiwa FO; Cao ZA; Chen HX; Ferris RL; Goldberg SB; Hellmann MD; Mehra R; Rhee I; Park JC; Kluger H; Tawbi H; Sullivan RJ
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36918220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance.
    Bagchi S; Yuan R; Engleman EG
    Annu Rev Pathol; 2021 Jan; 16():223-249. PubMed ID: 33197221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attribution of value for combination immune checkpoint inhibitors in non-small cell lung cancer.
    Zaim R; Redekop K; Uyl-de Groot CA
    J Cancer Policy; 2023 Mar; 35():100382. PubMed ID: 36592861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.
    Cohen R; Hain E; Buhard O; Guilloux A; Bardier A; Kaci R; Bertheau P; Renaud F; Bibeau F; Fléjou JF; André T; Svrcek M; Duval A
    JAMA Oncol; 2019 Apr; 5(4):551-555. PubMed ID: 30452494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer.
    Kobayashi Y; Lim SO; Yamaguchi H
    Semin Cancer Biol; 2020 Oct; 65():51-64. PubMed ID: 31874279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status and future perspective of immune checkpoint inhibitors in colorectal cancer.
    Zhou C; Cheng X; Tu S
    Cancer Lett; 2021 Aug; 521():119-129. PubMed ID: 34464671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing cure rates of solid tumors by immune checkpoint inhibitors.
    Ma W; Xue R; Zhu Z; Farrukh H; Song W; Li T; Zheng L; Pan CX
    Exp Hematol Oncol; 2023 Jan; 12(1):10. PubMed ID: 36647169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?
    Matteucci L; Bittoni A; Gallo G; Ridolfi L; Passardi A
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy with Immune Checkpoint Inhibitors for Advanced Colorectal Cancer: A Promising Individualized Treatment Strategy.
    Yang Y; Meng WJ; Wang ZQ
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):69. PubMed ID: 37114536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice.
    Carlino F; Diana A; Piccolo A; Ventriglia A; Bruno V; De Santo I; Letizia O; De Vita F; Daniele B; Ciardiello F; Orditura M
    Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.